|Min SIP Amount||Not Supported|
|NAV||₹7.05 (25 Sep 2020)|
|Fund Started||12 Mar 2018|
|Fund Size||₹451 Cr|
|RBL Bank Ltd.||Financial||Equity||5.9%|
|Nath Bio Genes (India) Ltd.||FMCG||Equity||4.8%|
|Cadila Healthcare Ltd.||Healthcare||Equity||4.1%|
|State Bank of India||Financial||Equity||4.0%|
|Mahindra & Mahindra Financial Services Ltd.||Financial||Equity||3.8%|
|Gujarat Narmada Valley Fertilizers & Chemicals Ltd.||Chemicals||Equity||3.6%|
|Avanti Feeds Ltd.||FMCG||Equity||3.5%|
|CCL Products (India) Ltd.||FMCG||Equity||3.3%|
|V-Mart Retail Ltd.||Services||Equity||3.2%|
|Hero Motocorp Ltd.||Automobile||Equity||2.9%|
Aditya Birla Sun Life Resurgent India Fund Series 6 Direct Growth is a Equity Mutual Fund Scheme launched by Aditya Birla Sun Life Mutual Fund. This scheme was made available to investors on 12 Mar 2018. Satyabrata Mohanty, Milind Bafna is the Current Fund Manager of Aditya Birla Sun Life Resurgent India Fund Series 6 Direct Growth fund.The fund currently has an Asset Under Management(AUM) of ₹451 Cr and the Latest NAV as of 25 Sep 2020 is ₹7.05.
The Aditya Birla Sun Life Resurgent India Fund Series 6 Direct Growth is rated Moderately High risk. Minimum SIP Investment is set to 1000.
The scheme seeks to provide capital appreciation by investing primarily in equity and equity related securities that are likely to benefit from recovery in the Indian economy.